Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor.

Raposeiras-Roubín S, Abu-Assi E, Muñoz-Pousa I, Cespón-Fernández M, Cobas-Paz R, Caneiro-Queija B, López-Rodríguez E, Pérez-Casares L, Jamhour-Chelh K, Castiñeira-Busto M, Barreiro-Pardal C, Calvo-Iglesias F, Íñiguez-Romo A.

Thromb Res. 2019 Feb;174:51-58. doi: 10.1016/j.thromres.2018.12.014. Epub 2018 Dec 8.

PMID:
30562722
2.

Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI.

Conrotto F, Bertaina M, Raposeiras-Roubin S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Quadri G, Varbella F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Abu-Assi E, D'Ascenzo F.

Eur Heart J Acute Cardiovasc Care. 2018 Oct 1:2048872618802783. doi: 10.1177/2048872618802783. [Epub ahead of print]

PMID:
30270638
3.

Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.

Raposeiras-Roubín S, Caneiro Queija B, D'Ascenzo F, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tomassini F, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Calvo-Iglesias F, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A, Abu-Assi E.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):215-223. doi: 10.1016/j.rec.2018.06.004. Epub 2018 Jul 18. English, Spanish.

PMID:
30029980
4.

Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.

Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Fernández-Barbeira S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tommassini F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):298-304. doi: 10.1016/j.rec.2018.05.021. Epub 2018 Jun 25. English, Spanish.

PMID:
29954720
5.

Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.

Caneiro-Queija B, Abu-Assi E, Raposeiras-Roubín S, Manzano-Fernández S, Flores Blanco P, López-Cuenca Á, Cobas-Paz R, Gómez-Molina M, Rodríguez-Rodríguez JM, Calvo-Iglesias F, Valdés-Chávarri M, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):829-836. doi: 10.1016/j.rec.2018.02.008. Epub 2018 Apr 12. English, Spanish.

PMID:
29656987
6.

Effect of beta-blocker dose on mortality after acute coronary syndrome.

Raposeiras-Roubin S, Abu-Assi E, Caneiro-Queija B, Cobas-Paz R, Rioboo-Lestón L, García Rodríguez C, Giraldez Lemos C, Blanco Vidal M, Ogando Guillán B, Pérez Martínez I, Paredes-Galán E, Jimenez-Díaz V, Baz-Alonso JA, Calvo-Iglesias F, Íñiguez-Romo A.

Rev Port Cardiol. 2018 Mar;37(3):239-245. doi: 10.1016/j.repc.2017.06.022. Epub 2018 Mar 30. English, Portuguese.

7.

Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score.

Raposeiras-Roubín S, Faxén J, Íñiguez-Romo A, Henriques JPS, D'Ascenzo F, Saucedo J, Szummer K, Jernberg T, James SK, Juanatey JRG, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Caneiro-Queija B, Cobas-Paz R, Acuña JMG, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Rivera-Asenjo D, Abu-Assi E.

Int J Cardiol. 2018 Mar 1;254:10-15. doi: 10.1016/j.ijcard.2017.10.103. Epub 2018 Jan 28.

PMID:
29407077
8.

Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients.

Abu-Assi E, Raposeiras-Roubin S, Cobas-Paz R, Caneiro-Queija B, Martínez-Reglero C, Rodríguez-Rodríguez JM, Baz A, Íñiguez-Romo A.

EuroIntervention. 2018 Mar 20;13(16):1914-1922. doi: 10.4244/EIJ-D-17-00550.

9.

Prognostic usefulness of an age-adapted equation for renal function assessment in older patients with acute coronary syndrome.

Rioboo Lestón L, Abu-Assi E, Raposeiras-Roubin S, Cobas-Paz R, Caneiro-Queija B, Rodríguez-Rodríguez JM, Íñiguez-Romo A.

Eur Heart J Acute Cardiovasc Care. 2018 Dec;7(8):703-709. doi: 10.1177/2048872617730040. Epub 2017 Sep 18.

PMID:
28920703
10.

Risk Scores From PARIS Registry: Are They Useful in a Contemporary Cohort of ACS Patients?

Raposeiras-Roubín S, Abu-Assi E, Rioboó-Lestón L, Míguez JO, Paz RC, Caneiro Queija B, Calvo Iglesias F, Iñiguez-Romo A.

J Am Coll Cardiol. 2016 Nov 29;68(21):2391-2392. doi: 10.1016/j.jacc.2016.05.104. No abstract available.

Supplemental Content

Loading ...
Support Center